Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on adolescent vaping

LIVE: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?
ADVANCED SEARCH
Log in
Top
Acta Neurologica Belgica

07-01-2025 | Insulins | Review article

Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease

Authors: Abhilasha Ahlawat, Vaibhav Walia, Munish Garg

Published in: Acta Neurologica Belgica

Login to get access

Abstract

Insulin resistance is a condition characterized by the attenuated biological response in the presence of normal or elevated insulin level and therefore is characterized by the impaired sensitivity to insulin and impaired glucose disposal and utilization. Insulin resistance in brain/Brain insulin resistance (BIR) is accompanied by the various manifestations including alteration in glucose sensing by hypothalamic neurons, impaired sympathetic outflow in response to hypoglycemia, increased ROS production, impaired mitochondrial oxygen consumption in the brain, cognitive deficits and neuronal cell damage. It has been reported that the disrupted insulin signaling is accompanied by the reduced expression of insulin receptor (IR)/insulin receptor substrate 1 (IRS1)/PI3K/AKT and IGF-1 receptor (IGF-1R)/IRS2/PI3K pathways. Insulin resistance and impaired insulin signaling interferes with the degradation and transportation of Aβ leading to Aβ deposition. Aβ promotes the hyperphosphorylation of tau, accumulation of neurofibrillary tangles and the later promotes the neuro-inflammation, apoptosis, oxidative stress, impairments of energy metabolism, synaptic disconnections, and hippocampus atrophy. Therefore, the impaired insulin signaling and the insulin promote cognitive deficits and neuronal cell death in the affected individuals. BIR is mainly responsible for the cognitive deficits and the neuronal damage in the patients of Alzheimer’s disease (AD). In the present work, authors describe the BIR, and its role in the emergence of cognitive deficits and neurodegeneration. Further, the emphasis has been given on the pharmacological agents that may alleviate the BIR and its deleterious effects.
Literature
Åberg MA, Åberg ND, Palmer TD, Alborn AM, Carlsson-Skwirut C, Bang P et al (2003) IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Mol Cell Neurosci 24:23–40PubMedCrossRef
Adzovic L, Domenici L (2014) Insulin induces phosphorylation of the AMPA receptor subunit GluR1, reversed by ZIP, and over-expression of protein kinase M zeta, reversed by amyloid beta. J Neurochem 131:582–587PubMedCrossRef
Afrezza [package insert] (2018) MannKind Corporation, Danbury, CT
Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem 275(12):9047–9054PubMedCrossRef
Ahuja S, Uniyal A, Akhtar A, Sah SP (2019) Alpha lipoic acid and metformin alleviates experimentally induced insulin resistance and cognitive deficit by modulation of TLR2 signalling. Pharmacol Rep 71(4):614–623PubMedCrossRef
Ajith TA (2018) A recent update on the effects of omega-3 fatty acids in Alzheimer’s disease. Curr Clin Pharmacol 13(4):252–260PubMedCrossRef
Amin FM, Hougaard A, Schytz HW, Asghar MS, Lundholm E, Parvaiz AI, Ashina M (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 137(3):779–794PubMedCrossRef
Apelt J, Mehlhorn G, Schliebs R (1999) Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3‐expressing cells and demonstrate a chemically distinct neuron‐specific localization in rat brain. J Neurosci Res 57(5):693–705PubMedCrossRef
Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Kim SF (2014) High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis 67:79–87PubMedPubMedCentralCrossRef
Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Reviews Neurol 14(3):168–181CrossRef
Ashraf A, Fan Z, Brooks DJ, Edison P (2015) Cortical hypermetabolism in MCI subjects: a compensatory mechanism? Eur J Nucl Med Mol Imaging 42:447–458PubMedCrossRef
Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson’s disease: mechanisms of action. Drug Discovery Today 21(5):802–818PubMedCrossRef
Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84(2):361–384PubMedCrossRef
Ayaz M, Sadiq A, Junaid M, Ullah F, Ovais M, Ullah I, Ahmed J, Shahid M (2019) Flavonoids as prospective neuroprotectants and their therapeutic propensity in Aging Associated Neurological disorders. Front Aging Neurosci 11:155
Bagyinszky E, Van Giau V, Shim K, Suk K, An SSA, Kim S (2017) Role of inflammatory molecules in the Alzheimer’s disease progression and diagnosis. J Neurol Sci 376:242–254PubMedCrossRef
Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68(1):51–57PubMedCrossRef
Banks WA, Jaspan JB, Kastin AJ (1997a) Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides 18(10):1577–1584PubMedCrossRef
Banks WA, Jaspan JB, Kastin AJ (1997b) Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 18:1257–1262PubMedCrossRef
Baura GD, Foster DM, Porte D, Kahn SE, Bergman RN, Cobelli C, Schwartz MW (1993) Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Investig 92(4):1824–1830PubMedPubMedCentralCrossRef
Baura GD, Foster DM, Kaiyala K, Porte D Jr, Kahn SE, Schwartz MW (1996) Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 45(1):86–90PubMedCrossRef
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38(3):357–366PubMedCrossRef
Benedict C, Hallschmid M, Hatke A et al (2004) Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29:1326–1334PubMedCrossRef
Benedict C, Hallschmid M, Schmitz K, Schultes B, Ratter F, Fehm HL et al (2007) Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32:239–243PubMedCrossRef
Benedict C, Brede S, Schiöth HB, Lehnert H, Schultes B, Born J et al (2011) Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. Diabetes 60(1):114e118CrossRef
Binder CB (1996) J. In: Porte D, Jr.; Sherwin, R, ed. Elenberg’s and Rifkin’s Diabetes Mellitus. 5th edition ed. Stamford, CT: Appleton and Lange;:689
Blázquez E, Velázquez E, Hurtado-Carneiro V, Ruiz-Albusac JM (2014) Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Front Endocrinol 5:161CrossRef
Bohringer A, Schwabe L, Richter S, Schachinger H (2008) Intranasal insulin attenuates the hypothalamic–pituitary–adrenal axis response to psychosocial stress. Psychoneuroendocrinology 33:1394–1400PubMedCrossRef
Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS (2001) Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 50:2652–2658PubMedCrossRef
Boitard C, Etchamendy N, Sauvant J, Aubert A, Tronel S, Marighetto A et al (2012) Juvenile, but not adult exposure to high-fat diet impairs relational memory and hippocampal neurogenesis in mice. Hippocampus 22:2095–2100PubMedCrossRef
Boumezbeur F, Petersen KF, Cline GW, Mason GF, Behar KL, Shulman GI, Rothman DL (2010) The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13 C nuclear magnetic resonance spectroscopy. J Neurosci 30(42):13983–13991PubMedPubMedCentralCrossRef
Breen DM, Rasmussen BA, Côté CD, Jackson VM, Lam TK (2013) Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes 62(9):3005–3013PubMedPubMedCentralCrossRef
Brief DJ, Davis JD (1984) Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain Res Bull 12(5):571–575PubMedCrossRef
Brooker GJ, Kalloniatis M, Russo VC, Murphy M, Werther GA, Bartlett PF (2000) Endogenous IGF-1 regulates the neuronal differentiation of adult stem cells. J Neurosci Res 59:332–341PubMedCrossRef
Broom GM, Shaw IC, Rucklidge JJ (2019) The ketogenic diet as a potential treatment and prevention strategy for Alzheimer’s disease. Nutrition 60:118–121PubMedCrossRef
Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metabol 7(2):95–96CrossRef
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRef
Brünner YF, Kofoet A, Benedict C, Freiherr J (2015) Central insulin administration improves odor-cued reactivation of spatial memory in young men. J Clin Endocrinol Metabolism 100:212–219CrossRef
Canhada S, Castro K, Perry IS, Luft VC (2018) Omega-3 fatty acids’ supplementation in Alzheimer’s disease: a systematic review. Nutr Neurosci 21:529–538PubMedCrossRef
Casas S, Casini P, Piquer S, Altirriba J, Soty M, Cadavez L, Gomis R, Novials A (2010) BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells. Am J Physiol Endocrinol Metab 299(6), E1087–E1095
Caselli RJ, Chen K, Lee W, Alexander GE, Reiman EM (2008) Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre–mild cognitive impairment. Arch Neurol 65(9):1231–1236PubMedCrossRef
Cedernaes J, Sand F, Liethof L, Lampola L, Hassanzadeh S, Axelsson EK et al (2016) Learning and sleep-dependent consolidation of spatial and procedural memories are unaltered in young men under a fixed short sleep schedule. Neurobiol Learn Mem 131:87–94PubMedCrossRef
Cedernaes J, Osorio RS, Varga AW, Kam K, Schiöth HB, Benedict C (2017) Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer’s disease. Sleep Med Rev 31:102–111PubMedCrossRef
Cetinkalp S, Simsir IY, Ertek S (2014) Insulin resistance in brain and possible therapeutic approaches. Curr Vasc Pharmacol 12(4):553–564PubMedCrossRef
Chapman CD, Frey WH, Craft S, Danielyan L, Hallschmid M, Schiöth HB, Benedict C (2013) Intranasal treatment of central nervous system dysfunction in humans. Pharm Res 30:2475–2484PubMedCrossRef
Chavez M, Kaiyala K, Madden LJ, Schwartz MW, Woods SC (1995) Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci 109(3):528PubMedCrossRef
Chen Y, Dong C (2009) Aβ40 promotes neuronal cell fate in neural progenitor cells. Cell Death Differ 16(3):386–394PubMedCrossRef
Chen TJ, Wang DC, Hung HS, Ho HF (2014a) Insulin can induce the expression of a memory-related synaptic protein through facilitating AMPA receptor endocytosis in rat cortical neurons. Cell Mol Life Sci 71:4069–4080PubMedPubMedCentralCrossRef
Chen Y, Run X, Liang Z, Zhao Y, Dai CL, Iqbal K, Liu F, Gong CX (2014b) Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice. Front Aging Neurosci 6:100PubMedPubMedCentralCrossRef
Chen Y, Zhao Y, Dai CL, Liang Z, Run X, Iqbal K, Liu F, Gong CX (2014c) Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice. Exp Neurol 261:610–619PubMedCrossRef
Chen Y, Yin M, Cao X, Hu G, Xiao M (2018) Pro- and anti-inflammatory effects of high cholesterol diet on aged brain. Aging Disorders 9:374–390CrossRef
Cholerton BRENNA, Baker LD, Craft SUZANNE (2011) Insulin resistance and pathological brain ageing. Diabet Med 28(12):1463–1475PubMedCrossRef
Christie JM, Wenthold RJ, Monaghan DT (1999) Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. J Neurochem 72:1523–1528PubMedCrossRef
Chudoba C, Wardelmann K, Kleinridders A (2019) Molecular effects of dietary fatty acids on brain insulin action and mitochondrial function. Biol Chem 400(8):991–1003PubMedCrossRef
Clauson PG, Linde B (1995) Absorption of rapid-acting insulin in obese and nonobese NIDDM patients. Diabetes Care 18(7):986–991PubMedCrossRef
Cornford EM, Hyman S (2005) Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx 2(1):27–43PubMedPubMedCentralCrossRef
Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS et al (2012) Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation. Brain Res 1441:64–78PubMedCrossRef
Craft, S., Baker, L. D., Montine, T. J., Minoshima, S., Watson, G. S., Claxton, A.,… Gerton, B. (2012). Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of neurology, 69(1), 29–38.
Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y et al (1996) Memory improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiol Aging 17:123–130PubMedCrossRef
Cukierman-Yaffee T (2009) The relationship between dysglycemia and cognitive dysfunction. Curr Opin Invest Drugs (London England: 2000) 10(1):70–74
d’Amico M, Di Filippo C, Marfella R, Abbatecola AM, Ferraraccio F, Rossi F, Paolisso G (2010) Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer’s prone mice. Exp Gerontol 45(3):202–207PubMedCrossRef
Daulatzai MA (2014) Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochem Res 39(4):624–644PubMedCrossRef
de la Monte, S. M., Lawton, M., Tong, M., Silbermann, E., Longato, L., Jiao, P.,…Wands, J. R. (2011). Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. In Handbook of animal models in Alzheimer’s disease (pp. 179–199). IOS Press.
de la Monte SM (2011) Contributions of brain insulin resistance and deficiency in amyloid-related neuro degeneration in Alzheimer’s disease. Drugs 72:1–18
de la Monte SM (2014) Relationships between diabetes and cognitive impairment. Endocrinol Metabolism Clin 43(1):245–267CrossRef
de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. J Alzheimers Dis 7(1):45–61PubMedCrossRef
de la Monte SM, Longato L, Tong M, Wands JR (2009) Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. Current opinion in investigational drugs (London, England: 2000), 10(10), 1049
de la Monte SM, Tong M, Nguyen V, Setshedi M, Longato L, Wands JR (2010) Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J Alzheimers Dis 21(3):967–984PubMedPubMedCentralCrossRef
de la Monte SM, Tong M, Bowling N, Moskal P (2011) si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder. Mol Brain 4(1):1–14
de la Monte SM, Re E, Longato L, Tong M (2012) Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer’s disease. J Alzheimers Dis 30(s2):S217–S229PubMedPubMedCentralCrossRef
de la Monte SM, Tong M, Wands JR (2018) The 20-year voyage aboard the journal of Alzheimer’s disease: docking at ‘Type 3 diabetes’, environmental/exposure factors, pathogenic mechanisms, and potential treatments. J Alzheimers Dis 62(3):1381–1390PubMedPubMedCentralCrossRef
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K.,… Zlokovic, B. V.(2004). LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron, 43(3), 333–344.
Decker RE, Chalif DJ (1991) Progressive coma after the transsphenoidal decompression of a pituitary adenoma with marked suprasellar extension: report of two cases. Neurosurgery 28(1):154–158PubMedCrossRef
Denver P, Gault VA, McClean PL (2018) Sustained high-fat diet modulates inflammation, insulin signalling and cognition in mice and a modified xenin peptide ameliorates neuropathology in a chronic high‐fat model. Diabetes Obes Metabolism 20(5):1166–1175CrossRef
Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS (1994) Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269(11):8445–8454PubMedCrossRef
Diaz, A., Muñoz-Arenas, G., Caporal‐Hernandez, K., Vázquez‐Roque, R., Lopez‐Lopez,G., Kozina, A.,… Guevara, J. (2021). Gallic acid improves recognition memory and decreases oxidative‐inflammatory damage in the rat hippocampus with metabolic syndrome.Synapse, 75(2), e22186.
Diekelmann S, Born J (2010) The memory function of sleep. Nat Reviews Neurosci 11:114–126CrossRef
Diggs-Andrews KA, Zhang X, Song Z, Daphna-Iken D, Routh VH, Fisher SJ (2010) Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia. Diabetes 59(9):2271e2280CrossRef
Dislich B, Lichtenthaler SF (2012) The membrane-bound aspartyl protease BACE1: Molecular and Functional properties in Alzheimer’s Disease and Beyond. Front Physiol 3:8PubMedPubMedCentralCrossRef
Dobarro M, Orejana L, Aguirre N, Ramírez MJ (2013) Propranolol reduces cognitive deficits, amyloid β levels, tau phosphorylation and insulin resistance in response to chronic corticosterone administration. Int J Neuropsychopharmacol 16(6):1351–1360PubMedCrossRef
Draznin B (2006) Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 55:2392–2397PubMedCrossRef
Du, L. L., Xie, J. Z., Cheng, X. S., Li, X. H., Kong, F. L., Jiang, X.,… Zhou, X.W. (2014). Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi. Age, 36, 613–623.
Duckworth WC, Bennett RG, Hamel FG (1998) Insulin Degradation: Progress Potential Endocr Rev, 19, 608–624PubMed
Duelli R, Kuschinsky W (2001) Brain glucose transporters: relationship to local energy demand. Physiology 16(2):71–76CrossRef
Duffy CM, Hofmeister JJ, Nixon JP, Butterick TA (2019) High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss. Neurobiol Learn Mem 157:41–47PubMedCrossRef
Ebeling P, Koistinen HA, Koivisto VA (1998) Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett 436(3):301–303PubMedCrossRef
Eguez L, Lee A, Chavez JA, Miinea CP, Kane S, Lienhard GE, McGraw TE (2005) Full intracellular retention of GLUT4 requires AS160 rab GTPase activating protein. Cell Metabol 2(4):263–272CrossRef
El-Mir, M. Y., Detaille, D., Delgado-Esteban, M., Guigas, B., Attia, S., Fontaine,E.,… Leverve, X. (2008). Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. Journal of Molecular Neuroscience, 34(1), 77–87.
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L.,… Kennedy, B. P. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science, 283(5407), 1544–1548.
Esmaeili MH, Enayati M, Abkenar FK, Ebrahimian F, Salari AA (2020) Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease. Behav Brain Res 379:112359PubMedCrossRef
Fadel JR, Reagan LP (2016) Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits. Curr Opin Behav Sci 9:47–54PubMedCrossRef
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P.,… Guénette, S. (2003). Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proceedings of the National Academy of Sciences, 100(7):4162–4167.
Foster LA, Ames NK, Emery RS (1991) Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol Behav 50(4):745–749PubMedCrossRef
Freeman LR, Granholm ACE (2012) Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet. J Cereb Blood Flow Metabolism 32(4):643–653CrossRef
Frid A, Linde B (1992) Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabet Med 9(3):236–239PubMedCrossRef
Frölich, L., Blum-Degen, D., Bernstein, H. G., Engelsberger, S., Humrich, J., Laufer,S.,… Riederer, P. (1998). Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. Journal of neural transmission, 105(4), 423–438.
Fusco, S., Ripoli, C., Podda, M. V., Ranieri, S. C., Leone, L., Toietta, G.,… Pani,G. (2012). A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proceedings of the National Academy of Sciences, 109(2), 621–626.
Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 277(50):48115–48121PubMedCrossRef
Gao Z, He Q, Peng B, Chiao PJ, Ye J (2006) Regulation of nuclear translocation of HDAC3 by IκBα is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor γ function. J Biol Chem 281(7):4540–4547PubMedCrossRef
Garcia-Serrano AM, Mohr AA, Philippe J, Skoug C, Spégel P, Duarte JM (2022) Cognitive impairment and metabolite profile alterations in the hippocampus and cortex of male and female mice exposed to a fat and sugar-rich diet are normalized by diet reversal. Aging Disease 13(1):267–283PubMedPubMedCentralCrossRef
Gault VA, Hölscher C (2008) GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol 587(1–3):112–117PubMedCrossRef
Ge Y, Dong Z, Bagot RC, Howland JG, Phillips AG, Wong TP, Wang YT (2010) Hippocampal long-term depression is required for the consolidation of spatial memory. Proceedings of the National Academy of Sciences, 107(38), 16697–16702
Gengler S, McClean PL, McCurtin R, Gault VA, Hölscher C (2012) Val (8) GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice. Neurobiol Aging 33(2):265–276PubMedCrossRef
Giau VV, Wu SY, Jamerlan A, An SSA, Kim S, Hulme J (2018) Gut microbiota and their neuroinflammatory implications in Alzheimer’s disease. Nutrients 10(11):1765PubMedPubMedCentralCrossRef
Gladding JM, Abbott KN, Antoniadis CP, Stuart A, Begg DP (2018) The effect of intrahippocampal insulin infusion on spatial cognitive function and markers of neuroinflammation in diet-induced obesity. Front Endocrinol 9:752CrossRef
Goldstein BJ, Ahmad F, Ding W, Li PM, Zhang WR (1998) Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol Cell Biochem 182(1):91–99PubMedCrossRef
Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M (2000) Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B: possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem 275(6):4283–4289PubMedCrossRef
Gonzalez E, McGraw TE (2006) Insulin signaling diverges into akt-dependent and-independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. Mol Biol Cell 17(10):4484–4493PubMedPubMedCentralCrossRef
Gonzalez SV, Nguyen NH, Rise F, Hassel B (2005) Brain metabolism of exogenous pyruvate. J Neurochem 95:284–293PubMedCrossRef
Gonzalez E, Flier E, Molle D, Accili D, McGraw TE (2011) Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proceedings of the National Academy of Sciences, 108(25), 10162–10167
Grayson BE, Seeley RJ, Sandoval DA (2013) Wired on sugar: the role of the CNS in the regulation of glucose homeostasis. Nat Rev Neurosci 14(1):24–37PubMedCrossRef
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D.,… Shulman,G. I. (1999). Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes, 48(6), 1270–1274.
Grillo, C. A., Piroli, G. G., Lawrence, R. C., Wrighten, S. A., Green, A. J., Wilson,S. P.,… Reagan, L. P. (2015). Hippocampal insulin resistance impairs spatial learning and synaptic plasticity. Diabetes, 64(11), 3927–3936.
Grünblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in Streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101(3):757–770PubMedCrossRef
Guo Z, Chen Y, Mao YF, Zheng T, Jiang Y, Yan Y, Yin X, Zhang B (2017b) Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model. Sci Rep 7:45971PubMedPubMedCentralCrossRef
Gupta A, Bisht B, Dey CS (2011) Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes. Neuropharmacology 60(6):910–920PubMedCrossRef
Havrankova J, Brownstein M, Roth J (1981) Insulin and insulin receptors in rodent brain. Diabetologia 20(1):268–273PubMedCrossRef
Heni, M., Schöpfer, P., Peter, A., Sartorius, T., Fritsche, A., Synofzik, M.,… Hennige,A. M. (2014). Evidence for altered transport of insulin across the blood–brain barrier in insulin-resistant humans. Acta diabetologica, 51, 679–681.
Heni M, Kullmann S, Preissl H, Fritsche A, Häring HU (2015) Impaired insulin action in the human brain: causes and metabolic consequences. Nat Reviews Endocrinol 11(12):701–711CrossRef
Hildebrandt P (1991a) Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients. Acta Physiol Scand Suppl 603:41–45PubMed
Hildebrandt P (1991b) Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors. Dan Med Bull 38(4):337–346PubMed
Hoffmeister A, Tuennemann J, Sommerer I, Mössner J, Rittger A, Schleinitz D, Kratzsch J, Rosendahl J, Klöting N, Stahl T, Rossner S, Paroni F, Maedler K, Kovacs P, Blüher M (2013) Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression. Obes (Silver Spring Md) 21(12):E626–E633
Holst JJ, Gromada J (2004) Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiology-Endocrinology Metabolism 287(2):E199–E206CrossRef
Houten MV, Posner BI, Kopriwa BM, Brawer JR (1979) Insulin-binding sites in the rat brain: in vivo localization to the circumventricular organs by quantitative radioautography. Endocrinology 105(3):666–673PubMedCrossRef
Hoyer S (2004a) Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Front Clin Neurosci 541:135–152
Hoyer S (2004b) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490(1–3):115–125PubMedCrossRef
Hoyer S, Nitsch R, Oesterreich K (1991) Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural transmission-Parkinson’s Disease Dement Sect. 3(1):1–14CrossRef
Hoyer S, Lee SK, Löffler T, Schliebs R (2000) Inhibition of the neuronal insulin receptor an in vivo model for sporadic Alzheimer disease? Ann N Y Acad Sci 920(1):256–258PubMedCrossRef
Hu, T., Lu, X. Y., Shi, J. J., Liu, X. Q., Chen, Q. B., Wang, Q.,… Zhang, S. J. (2020).Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice. Journal of cellular and molecular medicine, 24(6), 3449–3459.
Imfeld P, Bodmer M, Jick SS, Meier CR (2012) Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: a population-based case–control study. J Am Geriatr Soc 60(5):916–921PubMedCrossRef
Isik, A. T., Celik, T., Ulusoy, G., Ongoru, O., Elibol, B., Doruk, H.,… Akman, S.(2009). Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model. Age, 31(1), 39–49.
Israel, P. A., Park, C. R., Schwartz, M. W., Green, P. K., Sipols, A. J., Woods, S.C.,… Figlewicz, D. P. (1993). Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat. Brain research bulletin, 30(5–6), 571–575.
Iwai T, Ito S, Tanimitsu K, Udagawa S, Oka JI (2006) Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes. Neurosci Res 55(4):352–360PubMedCrossRef
Iwangoff P, Armbruster R, Enz A, Meier-Ruge W (1980) Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases. Mech Ageing Dev 14(1–2):203–209PubMedCrossRef
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P.,… Saido,T. C. (2001). Metabolic regulation of brain Aβ by neprilysin. Science, 292(5521), 1550–1552.
Jeong, H., Cohen, D. E., Cui, L., Supinski, A., Savas, J. N., Mazzulli, J. R.,… Krainc,D. (2012). Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nature medicine, 18(1), 159–165.
Jiang, Y., Li, L., Dai, C. L., Zhou, R., Gong, C. X., Iqbal, K.,… Liu, F. (2020).Effect of peripheral insulin administration on phosphorylation of tau in the brain.Journal of Alzheimer’s Disease, 75(4), 1377–1390.
Jumpertz R, Guijarro A, Pratley RE, Mason CC, Piomelli D, Krakoff J (2012) Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism. PLoS ONE, 7(7), e41503
Kamal A, Ramakers GM, Gispen WH, Biessels GJ, Ansari A, A (2013) Hyperinsulinemia in rats causes impairment of spatial memory and learning with defects in hippocampal synaptic plasticity by involvement of postsynaptic mechanisms. Exp Brain Res 226:45–51PubMedCrossRef
Kanoski SE, Davidson TL (2010) Different patterns of memory impairments accompany short-and longer-term maintenance on a high-energy diet. J Exp Psychol Anim Behav Process 36(2):313PubMedCrossRef
Karakelides H, Asmann YW, Bigelow ML, Short KR, Dhatariya K, Coenen-Schimke J, Kahl J, Mukhopadhyay D, Nair KS (2007) Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 56:2683–2689PubMedCrossRef
Kariharan, T., Nanayakkara, G., Parameshwaran, K., Bagasrawala, I., Ahuja, M., Abdel-Rahman,E.,… Amin, R. H. (2015). Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression. Neurobiology of aging, 36(3), 1451–1461.
Karmi A, Iozzo P, Viljanen A, Hirvonen J, Fielding BA, Virtanen K et al (2010) Increased brain fatty acid uptake in metabolic syndrome. Diabetes, 2010
Ketterer C, Tschritter O, Preissl H, Heni M, Häring HU, Fritsche A (2011) Insulin sensitivity of the human brain. Diabetes Res Clin Pract 93:S47–S51PubMedCrossRef
Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J.,…Schweiger, S. (2010). Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proceedings of the National Academy of Sciences, 107(50), 21830–21835.
Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C.,… McGowan,E. (2007). Aβ40 inhibits amyloid deposition in vivo. Journal of Neuroscience, 27(3), 627–633.
Kim, J. M., Park, C. H., Park, S. K., Seung, T. W., Kang, J. Y., Ha, J. S.,… Heo,H. J. (2017). Ginsenoside re ameliorates brain insulin resistance and cognitive dysfunction in high fat diet-induced C57BL/6 mice. Journal of Agricultural and Food Chemistry, 65(13), 2719–2729.
Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB (1999) Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Investig 104(6):733–741PubMedPubMedCentralCrossRef
Kim B, Elzinga SE, Henn RE, McGinley LM, Feldman EL (2019) The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer’s disease. Neurobiol Dis 132:104541PubMedPubMedCentralCrossRef
Kinhult J, Adner M, Uddman R, Cardell LO (2003) Pituitary adenylate cyclase-activating polypeptide, effects in the human nose. Clin Experimental Allergy 33(7):942–949CrossRef
Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J.M.,… Kahn, B. B. (2000). Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Molecular and cellular biology, 20(15), 5479–5489.
Kleinridders A, Könner AC, Brüning JC (2009) CNS-targets in control of energy and glucose homeostasis. Curr Opin Pharmacol 9(6):794–804
Koliaki C, Roden M (2016) Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus. Annu Rev Nutr 36:337–367PubMedCrossRef
Kong, D., Vong, L., Parton, L. E., Ye, C., Tong, Q., Hu, X.,… Lowell, B. B. (2010).Glucose stimulation of hypothalamic MCH neurons involves KATP channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell metabolism, 12(5), 545–552.
Kosaraju, J., Gali, C. C., Khatwal, R. B., Dubala, A., Chinni, S., Holsinger, R. D.,… Basavan, D. (2013). Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer’s disease. Neuropharmacology, 72, 291–300.
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O.,… Muoio, D. M. (2008). Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell metabolism, 7(1), 45–56.
Krikorian R, Eliassen JC, Boespflug EL, Nash TA, Shidler MD (2010) Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr Neurosci 13(3):116–122PubMedCrossRef
Krimbou L, Tremblay M, Davignon J, Cohn JS (1998) Association of apolipoprotein E with α2-macroglobulin in human plasma. J Lipid Res 39(12):2373–2386PubMedCrossRef
Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Haring HU (2016) Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev 96:1169–1209PubMedCrossRef
Labak M, Foniok T, Kirk D, Rushforth D, Tomanek B, Jasiński A, Grieb P(2010) Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease. Acta Neurochir Suppl 106:177–181CrossRef
Langbaum, J. B., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D.,… Reiman,E. M. (2010). Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E ε4 allele. Arch Neurol 67(4):462–468
Lauritzen T, Pramming S, Gale EA, Deckert T, Binder C (1982) Absorption of isophane (NPH) insulin and its clinical implications. BMJ 285(6336):159–162PubMedPubMedCentralCrossRef
Lee YH, White MF (2004) Insulin receptor substrate proteins and diabetes. Arch Pharm Res 27(4):361–370PubMedCrossRef
Lee CC, Huang CC, Hsu KS (2011) Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology 61:867–879PubMedCrossRef
Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral Streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease. J Alzheimers Dis 9(1):13–33PubMedCrossRef
Leto D, Saltiel AR (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13(6):383–396PubMedCrossRef
Leybaert L, De Bock M, Van Moorhem M, Decrock E, De Vuyst E (2007) Neurobarrier coupling in the brain: adjusting glucose entry with demand. J Neurosci Res 85(15):3213–3220PubMedCrossRef
Li S, Brown MS, Goldstein JL (2010) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proceedings of the national academy of sciences, 107(8), 3441–3446
Lindqvist A, Mohapel P, Bouter B, Frielingsdorf H, Pizzo D, Brundin P et al (2006) High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neurol 13:1385–1388PubMedCrossRef
Liu, Y., Fu, X., Lan, N., Li, S., Zhang, J., Wang, S.,… Zhang, L. (2014). Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behavioural brain research, 267, 178–188.
Liu L, Brown III, Webster JC, Morrisett WW, R. A., Monaghan DT (1995) Insulin potentiates N-methyl-D-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neurosci Lett 192(1):5–8PubMedCrossRef
Lochhead JJ, Wolak DJ, Pizzo ME, Thorne RG (2015) Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J Cereb Blood Flow Metabolism 35(3):371–381CrossRef
Lu J, Wu DM, Zheng YL, Hu B, Cheng W, Zhang ZF, Shan Q (2011a) Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and IκB kinase β/nuclear factor-κB-mediated inflammatory pathways in mice. Brain Behav Immun 25(8):1658–1667PubMedCrossRef
Lu J, Wu DM, Zheng ZH, Zheng YL, Hu B, Zhang ZF (2011b) Troxerutin protects against high cholesterol-induced cognitive deficits in mice. Brain 134(3):783–797PubMedCrossRef
Maedler K, Dharmadhikari G, Schumann DM, Størling J (2009) Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin Biol Ther 9(9):1177–1188PubMedCrossRef
Maher F, Davies-Hill TM, Lysko PG, Henneberry RC, Simpson IA (1991) Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: evidence for neuron-specific expression of GLUT3. Mol Cell Neurosci 2(4):351–360PubMedCrossRef
Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harbor Perspect Med 2(7):a006247CrossRef
Mao YF, Guo Z, Zheng T, Jiang Y, Yan Y, Yin X, Chen Y, Zhang B (2016) Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice. Aging Cell 15(5):893–902PubMedPubMedCentralCrossRef
Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T (2010) Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 75:764–770PubMedCrossRef
Matteucci E, Giampietro O, Covolan V, Giustarini D, Fanti P, Rossi R (2015) Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery. Drug Des Devel Ther 9:3109PubMedPubMedCentralCrossRef
McClean PL, Parthsarathy V, Faivre E, Hölscher C (2011) The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease. J Neurosci 31(17):6587–6594PubMedPubMedCentralCrossRef
McNay EC, Recknagel AK (2011) Reprint of:‘Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes’. Neurobiol Learn Mem 96(4):517–528PubMedCrossRef
McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS et al (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546–553PubMedPubMedCentralCrossRef
Meakin PJ, Harper AJ, Hamilton DL, Gallagher J, McNeilly AD, Burgess LA, Vaanholt LM, Bannon KA, Latcham J, Hussain I, Speakman JR, Howlett DR, Ashford ML (2012) Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem J 441(1):285–296PubMedCrossRef
Meakin PJ, Mezzapesa A, Benabou E, Haas ME, Bonardo B, Grino M, Brunel JM, Desbois-Mouthon C, Biddinger SB, Govers R, Ashford M, Peiretti F (2018) The beta secretase BACE1 regulates the expression of insulin receptor in the liver. Nature communications, 9(1), 1306
Mergenthaler P, Lindauer U, Dienel GA, Meisel A (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 36(10):587–597PubMedPubMedCentralCrossRef
Mielke JG, Taghibiglou C, Liu L, Zhang Y, Jia Z, Adeli K, Wang YT (2005) A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem 93(6):1568–1578PubMedCrossRef
Miller BW, Willett KC, Desilets AR (2011) Rosiglitazone and pioglitazone for the treatment of Alzheimer’s disease. Ann Pharmacother 45(11):1416–1424PubMedCrossRef
Mittal K, Mani RJ, Katare DP (2016) Type 3 diabetes: cross talk between differentially regulated proteins of type 2 diabetes mellitus and Alzheimer’s disease. Sci Rep 6(1):1–8CrossRef
Montgomery MK, Turner N (2015) Mitochondrial dysfunction and insulin resistance: an update. Endocr Connections 4(1):R1–R15CrossRef
Moreno S, Farioli-Vecchioli S, Ceru MP (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123(1):131–145PubMedCrossRef
Morgello S, Uson RR, Schwartz EJ, Haber RS (1995) The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia 14(1):43–54PubMedCrossRef
Morrison, C. D., Pistell, P. J., Ingram, D. K., Johnson, W. D., Liu, Y., Fernandez-Kim,S. O.,… Keller, J. N. (2010). High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling.Journal of neurochemistry, 114(6), 1581–1589.
Morselli, E., Fuente-Martin, E., Finan, B., Kim, M., Frank, A., Garcia-Caceres, C.,… Clegg, D. J. (2014). Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα. Cell reports, 9(2), 633–645.
Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486–510PubMedCrossRef
Mosconi, L., Mistur, R., Switalski, R., Tsui, W. H., Glodzik, L., Li, Y.,… de Leon,M. J. (2009). FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease. European journal of nuclear medicine and molecular imaging, 36(5), 811–822.
Mosconi, L., Mistur, R., Switalski, R., Tsui, W. H., Glodzik, L., Li, Y.,… de Leon,M. J. (2009). FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease. European journal of nuclear medicine and molecular imaging, 36, 811–822.
Mosconi L, Pupi A, De Leon MJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer’s disease. Ann N Y Acad Sci 1147(1):180–195PubMedPubMedCentralCrossRef
Mourya A, Akhtar A, Ahuja S, Sah SP, Kumar A (2018) Synergistic action of ursolic acid and metformin in experimental model of insulin resistance and related behavioral alterations. Eur J Pharmacol 835:31–40PubMedCrossRef
Murray AJ, Knight NS, Cochlin LE, McAleese S, Deacon RM, Rawlins JN et al (2009) Deterioration of physical performance and cognitive function in rats with short-term high-fat feeding. FASEB J 23:4353–4360PubMedCrossRef
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 32(1):193–203PubMedPubMedCentralCrossRef
Nguyen NH, Pham QT, Luong TNH, Le HK, Vo VG (2020a) Potential antidiabetic activity of extracts and isolated compound from Adenosma bracteosum (Bonati). Biomolecules 10(2):201PubMedPubMedCentralCrossRef
Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Van Giau V (2020b) Type 3 diabetes and its role implications in Alzheimer’s disease. Int J Mol Sci 21(9):3165PubMedPubMedCentralCrossRef
Nguyen TT, Ta QTH, Nguyen TTD, Le TT, Vo VG (2020c) Role of insulin resistance in the Alzheimer’s disease progression. Neurochem Res 45:1481–1491PubMedCrossRef
Novak, V., Milberg, W., Hao, Y., Munshi, M., Novak, P., Galica, A.,… Abduljalil,A. (2014). Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes care, 37(3), 751–759.
Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L (2002a) Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5(6):566–572PubMedCrossRef
Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L (2002b) Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51(2):271–275PubMedCrossRef
Obici S, Zhang BB, Karkanias G, Rossetti L (2002c) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8(12):1376–1382PubMedCrossRef
Omtri RS, Davidson MW, Arumugam B, Poduslo JF, Kandimalla KK (2012) Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer’s drug discovery. Mol Pharm 9(7):1887–1897PubMedPubMedCentralCrossRef
Park, J. H., Glass, Z., Sayed, K., Michurina, T. V., Lazutkin, A., Mineyeva, O.,…Enikolopov, G. (2013). Calorie restriction alleviates the age-related decrease in neural progenitor cell division in the aging brain. European Journal of Neuroscience, 37(12), 1987–1993.
Patel SS, Mehta V, Changotra H, Udayabanu M (2016) Depression mediates impaired glucose tolerance and cognitive dysfunction: a neuromodulatory role of rosiglitazone. Horm Behav 78:200–210PubMedCrossRef
Patti ME, Kahn CR (1996) Lessons from transgenic and knockout animals about noninsulin-dependent diabetes mellitus. Trends Endocrinol Metabolism 7(9):311–319CrossRef
Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199(2):265–273PubMedCrossRef
Peng, L., Fang, X., Xu, F., Liu, S., Qian, Y., Gong, X.,… Gu, X. (2021). Amelioration of Hippocampal Insulin Resistance Reduces Tau Hyperphosphorylation and Cognitive Decline Induced by Isoflurane in Mice. Frontiers in aging neuroscience, 13, 301.
Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM (1996) Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271(22):13018–13022PubMedCrossRef
Perhoc, A. B., Barilar, J. O., Knezovic, A., Farkas, V., Bagaric, R., Svarc, A.,…Salkovic-Petrisic, M. (2019). Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice. Neuropharmacology, 148, 50–67.
Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH (2003) Glucagon-like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron. J Neurosci Res 72(5):603–612PubMedCrossRef
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S.,… Shulman, G. I. (2007). The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proceedings of the National Academy of Sciences, 104(31), 12587–12594.
Pipatpiboon N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2012) PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 153(1):329–338PubMedCrossRef
Pocai, A., Lam, T. K., Gutierrez-Juarez, R., Obici, S., Schwartz, G. J., Bryan, J.,… Rossetti, L. (2005). Hypothalamic KATP channels control hepatic glucose production.Nature, 434(7036), 1026–1031.
Pocai A, Obici S, Schwartz GJ, Rossetti L (2005) A brain-liver circuit regulates glucose homeostasis. Cell Metabol 1(1):53–61CrossRef
Rajasekar N, Nath C, Hanif K, Shukla R (2017) Intranasal Insulin Administration ameliorates streptozotocin (ICV)-Induced insulin receptor dysfunction, Neuroinflammation, Amyloidogenesis, and memory impairment in rats. Mol Neurobiol 54(8):6507–6522PubMedCrossRef
Raskin P, Heller S, Honka M, Chang PC, Boss AH, Richardson PC, Amin N (2012) Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere insulin or usual antidiabetes treatment: a randomized trial. Diabetes Obes Metabolism 14(2):163–173CrossRef
Rave K, Heise T, PFutzner ANDREAS, Boss AH (2007) Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes. Diabetes Care 30(9):2307–2308PubMedCrossRef
Rave K, Heise T, Heinemann L, Boss AH (2008) Inhaled Technosphere® insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes. J Diabetes Sci Technol 2(2):205–212PubMedPubMedCentralCrossRef
Reddy PH (2014) Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction. J Alzheimers Dis 40(2):245–256PubMedPubMedCentralCrossRef
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton,B.,… Craft, S. (2008). Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology, 70(6), 440–448.
Reger, M. A., Watson, G., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A.,… Craft, S. (2008). Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults. Journal of Alzheimer’s disease, 13(3), 323–331.
Reger MA, Watson GS, Frey WH, Baker LD, Cholerton B, Keeling ML et al (2006a) Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27:451–458PubMedCrossRef
Reger MA, Watson GS, Frey IWH et al (2006b) Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27:451–458PubMedCrossRef
Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philosophical Trans Royal Soc B: Biol Sci 361(1473):1545–1564CrossRef
Reijmer YD, van den Berg E, Ruis C, Jaap Kappelle L, Biessels GJ (2010) Cognitive dysfunction in patients with type 2 diabetes. Diab/Metab Res Rev 26(7):507–519CrossRef
Requejo AM, Ortega RM, Robles F, Navia B, Faci M, Aparicio A (2003) Influence of nutrition on cognitive function in a group of elderly, independently living people. Eur J Clin Nutr 57(1):S54–S57PubMedCrossRef
Retnakaran R, Zinman B (2009) Thiazolidinediones and clinical outcomes in type 2 diabetes. Lancet 373(9681):2088–2090PubMedCrossRef
Rhea EM, Rask-Madsen C, Banks WA (2018) Insulin transport across the blood-brain barrier can occur independently of the insulin receptor. J Physiol 596(19):4753–4765PubMedPubMedCentralCrossRef
Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8(3):247–268PubMedCrossRef
Robinson MM, Soop M, Sohn TS, Morse DM, Schimke JM, Klaus KA, Nair KS (2014) High insulin combined with essential amino acids stimulates skeletal muscle mitochondrial protein synthesis while decreasing insulin sensitivity in healthy humans. J Clin Endocrinol Metabolism 99:E2574–E2583CrossRef
Rondinone CM et al (1997) Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 94:4171–4175PubMedPubMedCentralCrossRef
Rosen ED, Spiegelman BM (2001) PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276(41):37731–37734PubMedCrossRef
Rosenstock, J., Bergenstal, R., DeFronzo, R. A., Hirsch, I. B., Klonoff, D., Boss,A. H.,… Study Group. (2008). Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents. Diabetes Care, 31(11), 2177–2182.
Rosenstock, J., Lorber, D. L., Gnudi, L., Howard, C. P., Bilheimer, D. W., Chang,P. C.,… Richardson, P. C. (2010). Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. The Lancet, 375(9733), 2244–2253.
Rosenstock J, Cefalu WT, Hollander PA, Klioze SS, Reis J, Duggan WT (2009) Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial. Diabetes Technol Ther 11(11):697–705PubMedCrossRef
Ruegsegger, G. N., Vanderboom, P. M., Dasari, S., Klaus, K. A., Kabiraj, P., McCarthy,C. B.,… Nair, K. S. (2019). Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain. JCI insight, 4(18).
Rui, L., Aguirre, V., Kim, J. K., Shulman, G. I., Lee, A., Corbould, A.,… White,M. F. (2001). Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser 307 via distinct pathways. The Journal of clinical investigation, 107(2), 181–189.
Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Järvinen H (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49(5):749–758PubMedCrossRef
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N.,… IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice, 157, 107843.
Salameh, T. S., Bullock, K. M., Hujoel, I. A., Niehoff, M. L., Wolden-Hanson, T.,Kim, J.,… Banks, W. A. (2015). Central nervous system delivery of intranasal insulin:mechanisms of uptake and effects on cognition. Journal of Alzheimer’s Disease, 47(3), 715–728.
Salem MA, Budzyńska B, Kowalczyk J, Sayed E, N. S., Mansour SM (2021) Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer’s disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways. Toxicol Appl Pharmcol 429:115697CrossRef
Saltiel AR, Pessin JE (2003) Insulin signaling in microdomains of the plasma membrane. Traffic 4(11):711–716PubMedCrossRef
Sanchez-Alavez M, Osborn O, Tabarean IV, Holmberg KH, Eberwine J, Kahn CR et al (2011) Insulin-like growth factor 1-mediated hyperthermia in-volves anterior hypothalamic insulin receptors. J Biol Chem 286(17):14983e14990CrossRef
Sano, H., Eguez, L., Teruel, M. N., Fukuda, M., Chuang, T. D., Chavez, J. A.,… McGraw,T. E. (2007). Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell metabolism, 5(4), 293–303.
Santos MS, Pereira EM, Carvaho AP (1999) Stimulation of immunoreactive insulin release by glucose in rat brain synaptosomes. Neurochem Res 24(1):33–36PubMedCrossRef
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101PubMedCrossRef
Sartorius T, Peter A, Heni M, Maetzler W, Fritsche A, Häring HU, Hennige AM (2015) The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier? PLoS ONE, 10(5), e0126804
Schell M, Chudoba C, Leboucher A, Alfine E, Flore T, Ritter K et al (2020) Interplay of dietary fatty acids and cholesterol impacts brain mitochondria and insulin action. Nutrients 12(5):1518PubMedPubMedCentralCrossRef
Schwartz MW, Figlewicz DF, Kahn SE, Baskin DG, Greenwood MR, Porte D Jr. et al (1990) Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides 11:467–472PubMedCrossRef
Sharma S, Taliyan R (2014) Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice. Biochem Biophys Res Commun 452(4):1009–1015PubMedCrossRef
Shaw K (2017) Type 3’diabetes: a brain insulin-resistant state linked to Alzheimer’s disease. Practical Diabetes 34(6):187–188CrossRef
Shiba K, Kageyama H, Takenoya F, Shioda S (2010) Galanin-like peptide and the regulation of feeding behavior and energy metabolism. FEBS J 277(24):5006–5013PubMedCrossRef
Shiiki, T., Ohtsuki, S., Kurihara, A., Naganuma, H., Nishimura, K., Tachikawa, M.,… Terasaki, T. (2004). Brain insulin impairs amyloid-β (1–40) clearance from the brain. Journal of Neuroscience, 24(43), 9632–9637.
Shin, E. J., Kim, J. M., Kang, J. Y., Park, S. K., Han, H. J., Kim, H. J.,… Heo,H. J. (2021). Ameliorative effect of persimmon (Diospyros kaki) in cognitively impaired diabetic mice. Journal of Food Biochemistry, 45(1), e13581.
Shioda S, Kageyama H, Takenoya F, Shiba K (2011) Galanin-like peptide: a key player in the homeostatic regulation of feeding and energy metabolism? Int J Obes 35(5):619–628CrossRef
Siddiqui N, Ali J, Parvez S, Zameer S, Najmi AK, Akhtar M (2021) Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1– 42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer’s disease. Neuropharmacology 195:108662PubMedCrossRef
Sims-Robinson C, Bakeman A, Bruno E, Jackson S, Glasser R, Murphy GG, Feldman EL (2016) Dietary Reversal Ameliorates Short- and Long-Term Memory Deficits Induced by High-fat Diet Early in Life. PLoS One, 11(9), e0163883
Sindelka G, Heinemann L, Berger M, Frenck W, Chantelau E (1994) Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 37(4):377–380PubMedCrossRef
Skeberdis VA, Lan J-Y, Zheng X, Zukin SR, Bennett MV (2001) Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proc. Natl. Acad. Sci. U.S.A. 98, 3561–3566
Sleigh, A., Raymond-Barker, P., Thackray, K., Porter, D., Hatunic, M., Vottero, A.,… Savage, D. B. (2011). Mitochondrial dysfunction in patients with primary congenital insulin resistance. The Journal of clinical investigation, 121(6), 2457–2461.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedCrossRef
Sposato V, Canu N, Fico E, Fusco S, Bolasco G, Ciotti MT et al (2019) The medial septum is insulin resistant in the AD presymptomatic phase: rescue by nerve growth factor-driven IRS1 activation. Mol Neurobiol 56:535–552PubMedCrossRef
Sripetchwandee J, Chattipakorn N, Chattipakorn SC (2018) Links between obesity-Induced Brain insulin resistance, brain mitochondrial dysfunction, and Dementia. Front Endocrinol 9:496CrossRef
Stanley, M., Macauley, S. L., Caesar, E. E., Koscal, L. J., Moritz, W., Robinson,G. O.,… Holtzman, D. M. (2016). The effects of peripheral and central high insulin on brain insulin signaling and amyloid-β in young and old APP/PS1 mice. Journal of Neuroscience, 36(46), 11704–11715.
Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease–is this type 3 diabetes? J Alzheimer’s Disease 7:63–80CrossRef
Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP (2008) Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 11:309–317PubMedPubMedCentralCrossRef
Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS (2003) Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc. Natl. Acad. Sci. USA, 100, 7996–8001
Su Y, Lam TK, He W, Pocai A, Bryan J, Aguilar-Bryan L, Gutiérrez-Juárez R (2012) Hypothalamic leucine metabolism regulates liver glucose production. Diabetes 61(1):85–93PubMedCrossRef
Sumal KK, Blessing WW, Joh TH, Reis DJ, Pickel VM (1983) Synaptic interaction of vagal afferents and catecholaminergic neurons in the rat nucleus tractus solitarius. Brain Res 277(1):31–40PubMedCrossRef
Suzanne, M., Lyn-Cook Jr, L. E., Lawton, M., Tong, M., Silbermann, E., Longato, L.,… Wands, J. R. (2011). Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. Handbook of animal models in Alzheimer’s disease, 1, 179.
Swaminathan SK, Ahlschwede KM, Sarma V, Curran GL, Omtri RS, Decklever T, Lowe VJ, Poduslo JF, Kandimalla KK (2018) Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. J Cereb Blood flow Metabolism: Official J Int Soc Cereb Blood Flow Metabolism 38(5):904–918CrossRef
Takechi R, Galloway S, Pallebage-Gamarallage MMS, Lam V, Mamo JCL (2010) Dietary fats, cerebrovasculature integrity and Alzheimer’s disease risk. Prog Lipid Res 49(2):159–170PubMedCrossRef
Takeda S, Sato N, Uchio-Yamada K, Yu H, Moriguchi A, Rakugi H, Morishita R (2012) Oral glucose loading modulates plasma β-amyloid level in Alzheimer’s disease patients: potential diagnostic method for Alzheimer’s disease. Dement Geriatr Cogn Disord 34(1):25–30PubMedCrossRef
Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A et al (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338PubMedPubMedCentralCrossRef
Tamaki C, Ohtsuki S, Terasaki T (2007) Insulin facilitates the hepatic clearance of plasma amyloid β-peptide (1–40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes. Mol Pharmacol 72(4):850–855PubMedCrossRef
Tang, Y., Yu, C., Wu, J., Chen, H., Zeng, Y., Wang, X.,… Qin, D. (2018). Lychee seed extract protects against neuronal injury and improves cognitive function in rats with type II diabetes mellitus with cognitive impairment. International Journal of Molecular Medicine, 41(1), 251–263.
Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7(2):85–96PubMedCrossRef
ter Braak EW, Woodworth JR, Bianchi R, Cerimele B, Erkelens DW, Thijssen JH et al (1996) Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care 19:1437–1440PubMedCrossRef
Thirumangalakudi L, Prakasam A, Zhang R, Bimonte-Nelson H, Sambamurti K, Kindy MS et al (2008) High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 106:475–485PubMedPubMedCentralCrossRef
Tong M, de la Monte SM (2009) Mechanisms of ceramide-mediated neurodegeneration. J Alzheimer’s Disease: JAD 16(4):705–714CrossRef
Torsoni MA, Carvalheira JB, Pereira-Da-Silva M, de Carvalho-Filho MA, Saad MJ, Velloso LA (2003) Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold. Am J Physiology-Endocrinology Metabolism 285(1):E216–E223CrossRef
Tramutola A, Triplett JC, Di Domenico F, Niedowicz DM, Murphy MP, Coccia R et al (2015) Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. J Neurochem 133:739–749PubMedCrossRef
Trollor JN, Smith E, Agars E, Kuan SA, Baune BT, Campbell L et al (2012) The association between systemic inflammation and cognitive performance in the elderly: the sydney memory and ageing study. Age 34:1295–1308PubMedCrossRef
Tzatsos A (2009) Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR. J Biol Chem 284(34):22525–22534PubMedPubMedCentralCrossRef
Ueno, H., Mizuta, M., Shiiya, T., Tsuchimochi, W., Noma, K., Nakashima, N.,… Nakazato,M. (2014). Exploratory trial of intranasal administration of glucagon-like peptide-1 in Japanese patients with type 2 diabetes. Diabetes care, 37(7), 2024–2027.
Unger JW, Livingston JN, Moss AM (1991) Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36(5):343–362PubMedCrossRef
Van Der Heide LP, Kamal A, Artola A, Gispen WH, Ramakers GMJ (2005) Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem 94:1158–1166PubMedCrossRef
Vannucci SJ, Koehler-Stec EM, Li K, Reynolds TH, Clark R, Simpson IA (1998) GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res 797(1):1–11PubMedCrossRef
Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J.,… Newsholme,P. (2015). Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease. Mediators of inflammation, 2015.
Vinuesa, A., Pomilio, C., Menafra, M., Bonaventura, M. M., Garay, L., Mercogliano,M. F.,… Saravia, F. (2016). Juvenile exposure to a high fat diet promotes behavioral and limbic alterations in the absence of obesity. Psychoneuroendocrinology, 72, 22–33.
Vora JP, Burch A, Peters JR, Owens DR (1992) Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 15(11):1484–1493PubMedCrossRef
Vora JP, Burch A, Peters JR, Owens DR (1993) Absorption of radiolabeled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry. Diabet Med 10(8):736–743PubMedCrossRef
Wan, M., Leavens, K. F., Saleh, D., Easton, R. M., Guertin, D. A., Peterson, T. R.,… Birnbaum, M. J. (2011). Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell metabolism, 14(4), 516–527.
Wang, Q., Yuan, J., Yu, Z., Lin, L. I., Jiang, Y., Cao, Z.,… Wang, X. (2018). FGF21 attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice. Molecular neurobiology, 55(6), 4702–4717.
Wang R, Cruciani-Guglielmacci C, Migrenne S, Magnan C, Cotero VE, Routh VH (2006) Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol 95(3):1491–1498PubMedCrossRef
Wang MD, Huang Y, Zhang GP, Mao L, Xia YP, Mei YW, Hu B (2012) Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway. Neuroscience 226:388–396PubMedCrossRef
Wang D, Liu X, Liu Y, Shen G, Zhu X, Li S (2017) Treatment effects of Cardiotrophin-1 (CT-1) on streptozotocin-induced memory deficits in mice. Exp Gerontol 92:42–45PubMedCrossRef
Wang D, Liu L, Li S, Wang C (2018) Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive impairment in mice. Physiol Behav 191:12–20PubMedCrossRef
Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana,S.,… Craft, S. (2005). Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. The American journal of geriatric psychiatry, 13(11), 950–958.
Wei LT, Matsumoto H, Rhoads DE (1990) Release of immunoreactive insulin from rat brain synaptosomes under depolarizing conditions. Jorunal Neurochemistry 54(5):1661–1510CrossRef
Werther GA, Hogg A, Oldfield BJ McKin ley MJ, Figdor R, Allen AM, Mendelsohn FA (1987) Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology, 121, 1562–1570
White MF (2002) IRS proteins and the common path to diabetes. Am J Physiology-Endocrinology Metabolism 283(3):E413–E422CrossRef
White MF (2006) Regulating insulin signaling and β-cell function through IRS proteins. Can J Physiol Pharmacol 84(7):725–737PubMedCrossRef
Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT et al (2015) Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. JAMA Neurol 72:1013–1020PubMedPubMedCentralCrossRef
Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S (2016) Animal models of metabolic syndrome: a review. Nutr Metab 13:65CrossRef
Wong-Riley MT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12(3):94–101PubMedCrossRef
Woods SC, Lotter EC, McKay LD, Porte D (1979) Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282(5738):503–505PubMedCrossRef
Wu A, Ying Z, Gomez-Pinilla F (2004) The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 19:1699–1707PubMedCrossRef
Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M et al (2013) Sleep drives metabolite clearance from the adult brain. Science 342:373–377PubMedCrossRef
Yang Y, Song W (2013) Molecular links between Alzheimer’s disease and diabetes mellitus. Neuroscience 250:140–150PubMedCrossRef
Yang Y, Ma D, Wang Y, Jiang T, Hu S, Zhang M, Yu X, Gong CX (2013) Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimer’s Disease: JAD 33(2):329–338PubMedCrossRef
Yang R, Jiang X, He X, Liang D, Sun S, Zhou G (2020) Ginsenoside Rb1 improves cognitive impairment induced by insulin resistance through Cdk5/p35-NMDAR-IDE pathway. BioMed Research International, 2020
Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293(5535):1673–1677PubMedCrossRef
Zabielski P, Lanza IR, Gopala S, Heppelmann CJ, Bergen HR III, Dasari S, Nair KS (2016) Altered skeletal muscle mitochondrial proteome as the basis of disruption of mitochondrial function in diabetic mice. Diabetes 65:561–573PubMedCrossRef
Zhang, Y., Zhou, B., Deng, B., Zhang, F., Wu, J., Wang, Y.,… Zhai, Q. (2013). Amyloid-β induces hepatic insulin resistance in vivo via JAK2. Diabetes, 62(4), 1159–1166.
Zhang J, Gao Z, Yin J, Quon MJ, Ye J (2008) S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-α signaling through IKK2. J Biol Chem 283(51):35375–35382PubMedPubMedCentralCrossRef
Zhang T, Pan BS, Zhao B, Zhang LM, Huang YL, Sun FY (2009) Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of β-secretase activation and β-amyloid generation in rat brains. Neuroscience 161(4):1045–1056PubMedCrossRef
Zhang Y, Zhou B, Deng B, Zhang F, Wu J, Wang Y et al (2013) Amyloid-β induces hepatic insulin resistance in vivo via JAK2. Diabetes, 62, 1159–1166
Zhang H, Hao Y, Manor B, Novak P, Milberg W, Zhang J et al (2015) Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes 64:1025–1034PubMedCrossRef
Zhang L, Trushin S, Christensen TA, Bachmeier BV, Gateno B, Schroeder A et al (2016a) Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease. Sci Rep 6:1e12
Zhang Y, Dai CL, Chen Y, Iqbal K, Liu F, Gong CX (2016b) Intranasal insulin prevents Anesthesia-Induced spatial learning and memory deficit in mice. Sci Rep 6:21186PubMedPubMedCentralCrossRef
Metadata
Title
Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease
Authors
Abhilasha Ahlawat
Vaibhav Walia
Munish Garg
Publication date
07-01-2025
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-024-02706-7

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more
Image Credits